Halit Karaca

Summary

Publications

  1. ncbi request reprint Positive effects of oral β-glucan on mucositis and leukopenia in colorectal cancer patients receiving adjuvant FOLFOX-4 combination chemotherapy
    Halit Karaca
    Department of Medical Oncology, Erciyes University Medical Faculty, Kayseri, Turkey E mail
    Asian Pac J Cancer Prev 15:3641-4. 2014
  2. ncbi request reprint The prevalence of primary hereditary hemochromatosis in central Anatolia
    Halit Karaca
    Departments of Medical Oncology, Erciyes University School of Medicine, Kayseri, Turkey
    Turk J Gastroenterol 24:43-50. 2013
  3. doi request reprint Recovery of paraneoplastic hypercalcemia by sunitinib treatment for renal cell carcinoma: a case report and review of the literature
    Halit Karaca
    Department of Medical Oncology, Erciyes University Medical Faculty, Kayseri, Turkey
    Med Oncol 27:1023-6. 2010
  4. ncbi request reprint Association of human epidermal growth factor receptor-2 expression and clinicopathological findings in patients with colorectal cancer
    Halit Karaca
    Deparment of Medical Oncology, Erciyes University Medical Faculty, Kayseri, Turkey
    Asian Pac J Cancer Prev 13:6221-5. 2012
  5. ncbi request reprint Secondline chemotherapy versus best supportive care in patient with malignant pleural mesothelioma: a retrospective study
    Hasan Mutlu
    Department of Medical Oncology, ACIBADEM Kayseri Hospital, Kayseri, Turkey
    Asian Pac J Cancer Prev 14:3887-9. 2013
  6. ncbi request reprint Gemcitabine plus paclitaxel as second-line chemotherapy in patients with advanced non-small cell lung cancer
    Meltem Baykara
    Department of Medical Oncology, Sakarya University Training and Research Hospital, Sakarya, Turkey
    Asian Pac J Cancer Prev 13:5119-24. 2012
  7. ncbi request reprint Lack of prognostic value of mean corpuscular volume with capecitabine therapy in metastatic breast cancer
    Oktay Bozkurt
    Department of Medical Oncology, Erciyes University Faculty of Medicine, Kayseri, Turkey E mail
    Asian Pac J Cancer Prev 15:2501-4. 2014
  8. doi request reprint Prognostic value of tumor growth factor levels during chemotherapy in patients with metastatic colorectal cancer
    Mevlude Inanc
    Oncology Department, Mehmet Kemal Dedeman Onkoloji Hastanesi, Erciyes University, 38039, Kayseri, Turkey
    Med Oncol 29:3119-24. 2012
  9. doi request reprint Cytokeratin 5/6, c-Met expressions, and PTEN loss prognostic indicators in triple-negative breast cancer
    Mevlude Inanc
    Medical Oncology Department, Erciyes University, Kayseri, 38039, Turkey
    Med Oncol 31:801. 2014
  10. ncbi request reprint Efficacy and safety of raltitrexed combinations with uracil- tegafur or mitomycin C as salvage treatment in advanced colorectal cancer patients: a multicenter study of Anatolian Society of Medical Oncology (ASMO)
    Oktay Bozkurt
    Department of Medical Oncology, Faculty of Medicine, Erciyes University, Kayseri, Turkey E mail
    Asian Pac J Cancer Prev 15:1845-9. 2014

Collaborators

Detail Information

Publications25

  1. ncbi request reprint Positive effects of oral β-glucan on mucositis and leukopenia in colorectal cancer patients receiving adjuvant FOLFOX-4 combination chemotherapy
    Halit Karaca
    Department of Medical Oncology, Erciyes University Medical Faculty, Kayseri, Turkey E mail
    Asian Pac J Cancer Prev 15:3641-4. 2014
    ..Oral mucositis and diarrhea were less common in the β-glucan group. We conclude that β-glucan can be used to reduce the adverse effects of chemotherapy. ..
  2. ncbi request reprint The prevalence of primary hereditary hemochromatosis in central Anatolia
    Halit Karaca
    Departments of Medical Oncology, Erciyes University School of Medicine, Kayseri, Turkey
    Turk J Gastroenterol 24:43-50. 2013
    ..This study aimed to identify the prevalence of hereditary hemochromatosis in Kayseri and surroundings known as Central Anatolia...
  3. doi request reprint Recovery of paraneoplastic hypercalcemia by sunitinib treatment for renal cell carcinoma: a case report and review of the literature
    Halit Karaca
    Department of Medical Oncology, Erciyes University Medical Faculty, Kayseri, Turkey
    Med Oncol 27:1023-6. 2010
    ..Besides sunitinib is effective in symptom control, it is also helpful in management of paraneoplastic hypercalcemia, a life-threatening entity...
  4. ncbi request reprint Association of human epidermal growth factor receptor-2 expression and clinicopathological findings in patients with colorectal cancer
    Halit Karaca
    Deparment of Medical Oncology, Erciyes University Medical Faculty, Kayseri, Turkey
    Asian Pac J Cancer Prev 13:6221-5. 2012
    ....
  5. ncbi request reprint Secondline chemotherapy versus best supportive care in patient with malignant pleural mesothelioma: a retrospective study
    Hasan Mutlu
    Department of Medical Oncology, ACIBADEM Kayseri Hospital, Kayseri, Turkey
    Asian Pac J Cancer Prev 14:3887-9. 2013
    ..Secondline chemotherapy in MPM is still controversial and in this study we evaluated whether it is superior to best supportive care...
  6. ncbi request reprint Gemcitabine plus paclitaxel as second-line chemotherapy in patients with advanced non-small cell lung cancer
    Meltem Baykara
    Department of Medical Oncology, Sakarya University Training and Research Hospital, Sakarya, Turkey
    Asian Pac J Cancer Prev 13:5119-24. 2012
    ....
  7. ncbi request reprint Lack of prognostic value of mean corpuscular volume with capecitabine therapy in metastatic breast cancer
    Oktay Bozkurt
    Department of Medical Oncology, Erciyes University Faculty of Medicine, Kayseri, Turkey E mail
    Asian Pac J Cancer Prev 15:2501-4. 2014
    ..The present study investigated the clinical impact of MCV elevation in metastatic breast cancer patients treated with capecitabine...
  8. doi request reprint Prognostic value of tumor growth factor levels during chemotherapy in patients with metastatic colorectal cancer
    Mevlude Inanc
    Oncology Department, Mehmet Kemal Dedeman Onkoloji Hastanesi, Erciyes University, 38039, Kayseri, Turkey
    Med Oncol 29:3119-24. 2012
    ..However, meaningful increment was seen HGF levels in PD group. Angiogenic factors and E-selectin provided unique prognostic information in advanced colorectal carcinoma patients...
  9. doi request reprint Cytokeratin 5/6, c-Met expressions, and PTEN loss prognostic indicators in triple-negative breast cancer
    Mevlude Inanc
    Medical Oncology Department, Erciyes University, Kayseri, 38039, Turkey
    Med Oncol 31:801. 2014
    ....
  10. ncbi request reprint Efficacy and safety of raltitrexed combinations with uracil- tegafur or mitomycin C as salvage treatment in advanced colorectal cancer patients: a multicenter study of Anatolian Society of Medical Oncology (ASMO)
    Oktay Bozkurt
    Department of Medical Oncology, Faculty of Medicine, Erciyes University, Kayseri, Turkey E mail
    Asian Pac J Cancer Prev 15:1845-9. 2014
    ..Here we aimed to retrospectively evaluate the efficacy and tolerability of raltitrexed in combination with oral 5-fluoropyrimidine (uracil tegafur-UFT) or mitomycin C as salvage therapy in mCRC patients...
  11. ncbi request reprint Efficacy of sunitinib in Turkish patients with gastrointestinal stromal tumors; retrospective multicenter experience
    Umut Kefeli
    Department of Medical Oncology, Dr Lutfi Kirdar Kartal Education and Research Hospital, Istanbul, Turkey
    Hepatogastroenterology 60:647-52. 2013
    ..Sunitinib is a multi-targeted thyrosine kinase receptor inhibitor used in patients with advanced gastrointestinal stromal tumours (GISTs). We evaluated the efficacy and tolerability of sunitinib therapy in Turkish patients with GISTs...
  12. ncbi request reprint Docetaxel and cisplatin in first line treatment of patients with unknown primary cancer: a multicenter study of the Anatolian Society of Medical Oncology
    Umut Demirci
    Department of Medical Oncology, Dr A Y Ankara Oncology Training and Research Hospital, Ankara, Turkey E mail
    Asian Pac J Cancer Prev 15:1581-4. 2014
    ..The overall prognosis for cancers of unknown primary (CUP) is poor, median overall survival (OS) being 6-12 months. We evaluated our multicentric retrospective experience for CUP administered docetaxel and cisplatin combination therapy...
  13. ncbi request reprint Haematologic parameters in metastatic colorectal cancer patients treated with capecitabine combination therapy
    Mevlude Inanc
    Kayseri Training and Research Hospital, Kayseri, Turkey E mail
    Asian Pac J Cancer Prev 15:253-6. 2014
    ..PCT and PLT values were higher in patients who received Bevacizumab than those who did not. MCV, PLT, and NLR can be considered as important factors in predicting response to colorectal carcinoma treatment. ..
  14. ncbi request reprint Prognostic value of excision repair cross-complementing gene 1 expression for cisplatin-based chemotherapy in advanced gastric cancer
    Metin Ozkan
    Department of Medical Oncology, Medical Faculty, Erciyes University, Kayseri, Turkey
    Asian Pac J Cancer Prev 11:181-5. 2010
    ..Association of excision repair cross-complementing gene 1 (ERCC1) expression and treatment response and survival was evaluated in advanced stages of gastric cancer patients who were given different platinum-based chemotherapy...
  15. ncbi request reprint Second-line gemcitabine-based chemotherapy regimens improve overall 3-year survival rate in patients with malignant pleural mesothelioma: a multicenter retrospective study
    Hasan Mutlu
    Department of Medical Oncology, ACIBADEM Kayseri Hospital, Kayseri, Turkey
    Med Oncol 31:74. 2014
    ..005). According to our results, we may consider gemcitabine-based regimens as second-line chemotherapy after treatment with pemetrexed plus platinum in patients with MPM. ..
  16. doi request reprint Moxifloxacin-associated neutropenia
    Veli Berk
    Deparment of Medical Oncology, Erciyes University Medical School, Kayseri, Turkey
    Scand J Infect Dis 45:415-6. 2013
    ..After discontinuing the moxifloxacin, neutrophil counts were normal on day 4. Clinicians should be aware of the possibility of this adverse effect in patients treated with moxifloxacin...
  17. doi request reprint Results of adjuvant FOLFOX regimens in stage III colorectal cancer patients: retrospective analysis of 667 patients
    Dogan Uncu
    Department of Medical Oncology, Ankara Numune Education and Research Hospital, Ankara, Turkey
    Oncology 84:240-5. 2013
    ..The aim of this study was to assess the use of 5-fluorouracil (5-FU), leucovorin and oxaliplatin (FOLFOX) regimens in clinical practice according to their efficacy and toxicity...
  18. doi request reprint Bevacizumab plus irinotecan in recurrent or progressive malign glioma: a multicenter study of the Anatolian Society of Medical Oncology (ASMO)
    Umut Demirci
    Department of Medical Oncology, Ataturk Training and Research Hospital, Bilkent, Ankara 0906800, Turkey
    J Cancer Res Clin Oncol 139:829-35. 2013
    ..We evaluated our multicenter retrospective experience for patients with recurrent MG administering bevacizumab and irinotecan in combination therapy...
  19. doi request reprint Refractory generalized seizures as a possible side effect of bevacizumab in a colon cancer patient
    Veli Berk
    Department of Medical Oncology, Erciyes University Medical School, 38039 Kayseri, Turkey
    Med Oncol 29:1017-9. 2012
    ..We describe a patient who presented with refractory generalized tonic-clonic seizures after receiving last dose of bevacizumab for treatment of metastatic colorectal cancer with FOLFIRI and bevacizumab regimen...
  20. doi request reprint Protective effects of nebivolol against anthracycline-induced cardiomyopathy: a randomized control study
    Mehmet G Kaya
    Department of Cardiology, Erciyes University School of Medicine, Kayseri, Turkey
    Int J Cardiol 167:2306-10. 2013
    ..We aimed to evaluate the effect of prophylactic nebivolol use on prevention of antracycline-induced cardiotoxicity in breast cancer patients...
  21. doi request reprint Nuclear factor-kappa B ligand and osteoprotegerin levels in serum and gingival crevicular fluid in patients with bone metastases treated with zoledronic acid
    Mevlude Inanc
    Medical Oncology Department, Kayseri Training and Research Hospital, Kayseri, 38039, Turkey
    Med Oncol 31:837. 2014
    ..OPG levels were greater in patients with 5 or more bone metastases. In patients diagnosed with multiple myeloma, GCF OPG levels were negatively associated with WBC and platelet counts...
  22. ncbi request reprint Treatment regimen with bevacizumab decreases mean platelet volume in patients with metastatic colon cancer
    Hasan Mutlu
    Medical Oncology Department, Kayseri Education and Research Hospital, Kayseri, Turkey
    Clin Appl Thromb Hemost 18:546-8. 2012
    ..009, P = .001, and P = .000, respectively). Unlike cases with thrombosis, there is a significant decrease in MPV in combination treatments with bevacizumab...
  23. ncbi request reprint ERCC1 as a Biological Marker Guiding Management in Malignant Pleural Mesothelioma
    Yasemin Benderli Cihan
    Department of Radiation Oncology, Kayseri Education and Research Hospital, Kayseri, Turkey E mail
    Asian Pac J Cancer Prev 15:4117-23. 2014
    ..005). In univariate and multivariate analyses, response to treatment and ERCC1 were found to be significantly associated with DFS (p=0.049; p=0.041). Conclusions: ERCC1 was identified as poor prognostic factor in patients with MPM. ..
  24. doi request reprint Bevacizumab every 4 weeks is as effective as every 2 weeks in combination with biweekly FOLFIRI in metastatic colorectal cancer
    Ramazan Yildiz
    Departments of Medical Oncology, Gazi University Faculty of Medicine, Besevler, 06500 Ankara, Turkey
    J Cancer Res Clin Oncol 138:1845-52. 2012
    ....
  25. pmc Concomitant chemoradiotherapy with docetaxel and cisplatin followed by consolidation chemotherapy in locally advanced unresectable non-small cell lung cancer
    Celalettin Eroglu
    Department of Radiation Oncology, Erciyes University, School of Medicine, Kayseri, Turkey
    Ann Thorac Med 8:109-15. 2013
    ..To evaluate treatment results and toxicities in patients who received concomitant chemoradiotherapy (CRT) followed by consolidation with docetaxel and cisplatin in locally advanced unresectable non-small cell lung cancer (NSCLC)...